Summary

The global Pregabalin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
LP Information, Inc. (LPI) ' newest research report, the “Pregabalin Industry Forecast” looks at past sales and reviews total world Pregabalin sales in 2024, providing a comprehensive analysis by region and market sector of projected Pregabalin sales for 2025 through 2031. With Pregabalin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pregabalin industry.
This Insight Report provides a comprehensive analysis of the global Pregabalin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pregabalin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pregabalin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pregabalin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pregabalin.
This report presents a comprehensive overview, market shares, and growth opportunities of Pregabalin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tablet
Capsule
Oral Solution
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pregabalin market?
What factors are driving Pregabalin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pregabalin market opportunities vary by end market size?
How does Pregabalin break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pregabalin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pregabalin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pregabalin by Country/Region, 2020, 2024 & 2031
2.2 Pregabalin Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Oral Solution
2.3 Pregabalin Sales by Type
2.3.1 Global Pregabalin Sales Market Share by Type (2020-2025)
2.3.2 Global Pregabalin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pregabalin Sale Price by Type (2020-2025)
2.4 Pregabalin Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Pregabalin Sales by Application
2.5.1 Global Pregabalin Sale Market Share by Application (2020-2025)
2.5.2 Global Pregabalin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pregabalin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pregabalin Breakdown Data by Company
3.1.1 Global Pregabalin Annual Sales by Company (2020-2025)
3.1.2 Global Pregabalin Sales Market Share by Company (2020-2025)
3.2 Global Pregabalin Annual Revenue by Company (2020-2025)
3.2.1 Global Pregabalin Revenue by Company (2020-2025)
3.2.2 Global Pregabalin Revenue Market Share by Company (2020-2025)
3.3 Global Pregabalin Sale Price by Company
3.4 Key Manufacturers Pregabalin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pregabalin Product Location Distribution
3.4.2 Players Pregabalin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pregabalin by Geographic Region
4.1 World Historic Pregabalin Market Size by Geographic Region (2020-2025)
4.1.1 Global Pregabalin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pregabalin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pregabalin Market Size by Country/Region (2020-2025)
4.2.1 Global Pregabalin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pregabalin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pregabalin Sales Growth
4.4 APAC Pregabalin Sales Growth
4.5 Europe Pregabalin Sales Growth
4.6 Middle East & Africa Pregabalin Sales Growth
5 Americas
5.1 Americas Pregabalin Sales by Country
5.1.1 Americas Pregabalin Sales by Country (2020-2025)
5.1.2 Americas Pregabalin Revenue by Country (2020-2025)
5.2 Americas Pregabalin Sales by Type (2020-2025)
5.3 Americas Pregabalin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pregabalin Sales by Region
6.1.1 APAC Pregabalin Sales by Region (2020-2025)
6.1.2 APAC Pregabalin Revenue by Region (2020-2025)
6.2 APAC Pregabalin Sales by Type (2020-2025)
6.3 APAC Pregabalin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pregabalin by Country
7.1.1 Europe Pregabalin Sales by Country (2020-2025)
7.1.2 Europe Pregabalin Revenue by Country (2020-2025)
7.2 Europe Pregabalin Sales by Type (2020-2025)
7.3 Europe Pregabalin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pregabalin by Country
8.1.1 Middle East & Africa Pregabalin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pregabalin Revenue by Country (2020-2025)
8.2 Middle East & Africa Pregabalin Sales by Type (2020-2025)
8.3 Middle East & Africa Pregabalin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pregabalin
10.3 Manufacturing Process Analysis of Pregabalin
10.4 Industry Chain Structure of Pregabalin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pregabalin Distributors
11.3 Pregabalin Customer
12 World Forecast Review for Pregabalin by Geographic Region
12.1 Global Pregabalin Market Size Forecast by Region
12.1.1 Global Pregabalin Forecast by Region (2026-2031)
12.1.2 Global Pregabalin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pregabalin Forecast by Type (2026-2031)
12.7 Global Pregabalin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ZCL Chemicals
13.1.1 ZCL Chemicals Company Information
13.1.2 ZCL Chemicals Pregabalin Product Portfolios and Specifications
13.1.3 ZCL Chemicals Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ZCL Chemicals Main Business Overview
13.1.5 ZCL Chemicals Latest Developments
13.2 Olon S.p.A.
13.2.1 Olon S.p.A. Company Information
13.2.2 Olon S.p.A. Pregabalin Product Portfolios and Specifications
13.2.3 Olon S.p.A. Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Olon S.p.A. Main Business Overview
13.2.5 Olon S.p.A. Latest Developments
13.3 AASraw Biochemical Technology
13.3.1 AASraw Biochemical Technology Company Information
13.3.2 AASraw Biochemical Technology Pregabalin Product Portfolios and Specifications
13.3.3 AASraw Biochemical Technology Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AASraw Biochemical Technology Main Business Overview
13.3.5 AASraw Biochemical Technology Latest Developments
13.4 Changzhou Pharmaceutical Factory (CPF)
13.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
13.4.2 Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolios and Specifications
13.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Changzhou Pharmaceutical Factory (CPF) Main Business Overview
13.4.5 Changzhou Pharmaceutical Factory (CPF) Latest Developments
13.5 Almelo Pvt. Ltd.
13.5.1 Almelo Pvt. Ltd. Company Information
13.5.2 Almelo Pvt. Ltd. Pregabalin Product Portfolios and Specifications
13.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Almelo Pvt. Ltd. Main Business Overview
13.5.5 Almelo Pvt. Ltd. Latest Developments
13.6 Divi’s Laboratories
13.6.1 Divi’s Laboratories Company Information
13.6.2 Divi’s Laboratories Pregabalin Product Portfolios and Specifications
13.6.3 Divi’s Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Divi’s Laboratories Main Business Overview
13.6.5 Divi’s Laboratories Latest Developments
13.7 Angels Pharma
13.7.1 Angels Pharma Company Information
13.7.2 Angels Pharma Pregabalin Product Portfolios and Specifications
13.7.3 Angels Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Angels Pharma Main Business Overview
13.7.5 Angels Pharma Latest Developments
13.8 ARITE Pharmaceutical
13.8.1 ARITE Pharmaceutical Company Information
13.8.2 ARITE Pharmaceutical Pregabalin Product Portfolios and Specifications
13.8.3 ARITE Pharmaceutical Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 ARITE Pharmaceutical Main Business Overview
13.8.5 ARITE Pharmaceutical Latest Developments
13.9 BAL Pharma
13.9.1 BAL Pharma Company Information
13.9.2 BAL Pharma Pregabalin Product Portfolios and Specifications
13.9.3 BAL Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BAL Pharma Main Business Overview
13.9.5 BAL Pharma Latest Developments
13.10 Bazayan
13.10.1 Bazayan Company Information
13.10.2 Bazayan Pregabalin Product Portfolios and Specifications
13.10.3 Bazayan Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bazayan Main Business Overview
13.10.5 Bazayan Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Pregabalin Product Portfolios and Specifications
13.11.3 Aurobindo Pharma Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Hikal
13.12.1 Hikal Company Information
13.12.2 Hikal Pregabalin Product Portfolios and Specifications
13.12.3 Hikal Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hikal Main Business Overview
13.12.5 Hikal Latest Developments
13.13 Glenmark Life Sciences
13.13.1 Glenmark Life Sciences Company Information
13.13.2 Glenmark Life Sciences Pregabalin Product Portfolios and Specifications
13.13.3 Glenmark Life Sciences Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Glenmark Life Sciences Main Business Overview
13.13.5 Glenmark Life Sciences Latest Developments
13.14 Dongbang FTL
13.14.1 Dongbang FTL Company Information
13.14.2 Dongbang FTL Pregabalin Product Portfolios and Specifications
13.14.3 Dongbang FTL Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dongbang FTL Main Business Overview
13.14.5 Dongbang FTL Latest Developments
13.15 Teva Pharmaceutical Industries
13.15.1 Teva Pharmaceutical Industries Company Information
13.15.2 Teva Pharmaceutical Industries Pregabalin Product Portfolios and Specifications
13.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Teva Pharmaceutical Industries Main Business Overview
13.15.5 Teva Pharmaceutical Industries Latest Developments
13.16 Divi’s Laboratories
13.16.1 Divi’s Laboratories Company Information
13.16.2 Divi’s Laboratories Pregabalin Product Portfolios and Specifications
13.16.3 Divi’s Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Divi’s Laboratories Main Business Overview
13.16.5 Divi’s Laboratories Latest Developments
13.17 Chemo Iberica
13.17.1 Chemo Iberica Company Information
13.17.2 Chemo Iberica Pregabalin Product Portfolios and Specifications
13.17.3 Chemo Iberica Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Chemo Iberica Main Business Overview
13.17.5 Chemo Iberica Latest Developments
13.18 Maps Laboratories
13.18.1 Maps Laboratories Company Information
13.18.2 Maps Laboratories Pregabalin Product Portfolios and Specifications
13.18.3 Maps Laboratories Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Maps Laboratories Main Business Overview
13.18.5 Maps Laboratories Latest Developments
13.19 Laurus Labs
13.19.1 Laurus Labs Company Information
13.19.2 Laurus Labs Pregabalin Product Portfolios and Specifications
13.19.3 Laurus Labs Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Laurus Labs Main Business Overview
13.19.5 Laurus Labs Latest Developments
13.20 Zhejiang Huahai Pharmaceutical
13.20.1 Zhejiang Huahai Pharmaceutical Company Information
13.20.2 Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolios and Specifications
13.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.20.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.21 Vasudha Pharma Chem
13.21.1 Vasudha Pharma Chem Company Information
13.21.2 Vasudha Pharma Chem Pregabalin Product Portfolios and Specifications
13.21.3 Vasudha Pharma Chem Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Vasudha Pharma Chem Main Business Overview
13.21.5 Vasudha Pharma Chem Latest Developments
13.22 Sun Pharmaceutical Industries
13.22.1 Sun Pharmaceutical Industries Company Information
13.22.2 Sun Pharmaceutical Industries Pregabalin Product Portfolios and Specifications
13.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Sun Pharmaceutical Industries Main Business Overview
13.22.5 Sun Pharmaceutical Industries Latest Developments
13.23 CTX Life Sciences
13.23.1 CTX Life Sciences Company Information
13.23.2 CTX Life Sciences Pregabalin Product Portfolios and Specifications
13.23.3 CTX Life Sciences Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 CTX Life Sciences Main Business Overview
13.23.5 CTX Life Sciences Latest Developments
13.24 Srini Pharmaceuticals
13.24.1 Srini Pharmaceuticals Company Information
13.24.2 Srini Pharmaceuticals Pregabalin Product Portfolios and Specifications
13.24.3 Srini Pharmaceuticals Pregabalin Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Srini Pharmaceuticals Main Business Overview
13.24.5 Srini Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Pregabalin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pregabalin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Major Players of Oral Solution
Table 6. Global Pregabalin Sales by Type (2020-2025) & (K MT)
Table 7. Global Pregabalin Sales Market Share by Type (2020-2025)
Table 8. Global Pregabalin Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pregabalin Revenue Market Share by Type (2020-2025)
Table 10. Global Pregabalin Sale Price by Type (2020-2025) & (USD/MT)
Table 11. Global Pregabalin Sale by Application (2020-2025) & (K MT)
Table 12. Global Pregabalin Sale Market Share by Application (2020-2025)
Table 13. Global Pregabalin Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pregabalin Revenue Market Share by Application (2020-2025)
Table 15. Global Pregabalin Sale Price by Application (2020-2025) & (USD/MT)
Table 16. Global Pregabalin Sales by Company (2020-2025) & (K MT)
Table 17. Global Pregabalin Sales Market Share by Company (2020-2025)
Table 18. Global Pregabalin Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pregabalin Revenue Market Share by Company (2020-2025)
Table 20. Global Pregabalin Sale Price by Company (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Pregabalin Producing Area Distribution and Sales Area
Table 22. Players Pregabalin Products Offered
Table 23. Pregabalin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pregabalin Sales by Geographic Region (2020-2025) & (K MT)
Table 27. Global Pregabalin Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pregabalin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pregabalin Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pregabalin Sales by Country/Region (2020-2025) & (K MT)
Table 31. Global Pregabalin Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pregabalin Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pregabalin Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pregabalin Sales by Country (2020-2025) & (K MT)
Table 35. Americas Pregabalin Sales Market Share by Country (2020-2025)
Table 36. Americas Pregabalin Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pregabalin Sales by Type (2020-2025) & (K MT)
Table 38. Americas Pregabalin Sales by Application (2020-2025) & (K MT)
Table 39. APAC Pregabalin Sales by Region (2020-2025) & (K MT)
Table 40. APAC Pregabalin Sales Market Share by Region (2020-2025)
Table 41. APAC Pregabalin Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pregabalin Sales by Type (2020-2025) & (K MT)
Table 43. APAC Pregabalin Sales by Application (2020-2025) & (K MT)
Table 44. Europe Pregabalin Sales by Country (2020-2025) & (K MT)
Table 45. Europe Pregabalin Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pregabalin Sales by Type (2020-2025) & (K MT)
Table 47. Europe Pregabalin Sales by Application (2020-2025) & (K MT)
Table 48. Middle East & Africa Pregabalin Sales by Country (2020-2025) & (K MT)
Table 49. Middle East & Africa Pregabalin Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pregabalin Sales by Type (2020-2025) & (K MT)
Table 51. Middle East & Africa Pregabalin Sales by Application (2020-2025) & (K MT)
Table 52. Key Market Drivers & Growth Opportunities of Pregabalin
Table 53. Key Market Challenges & Risks of Pregabalin
Table 54. Key Industry Trends of Pregabalin
Table 55. Pregabalin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pregabalin Distributors List
Table 58. Pregabalin Customer List
Table 59. Global Pregabalin Sales Forecast by Region (2026-2031) & (K MT)
Table 60. Global Pregabalin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pregabalin Sales Forecast by Country (2026-2031) & (K MT)
Table 62. Americas Pregabalin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pregabalin Sales Forecast by Region (2026-2031) & (K MT)
Table 64. APAC Pregabalin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pregabalin Sales Forecast by Country (2026-2031) & (K MT)
Table 66. Europe Pregabalin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pregabalin Sales Forecast by Country (2026-2031) & (K MT)
Table 68. Middle East & Africa Pregabalin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pregabalin Sales Forecast by Type (2026-2031) & (K MT)
Table 70. Global Pregabalin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pregabalin Sales Forecast by Application (2026-2031) & (K MT)
Table 72. Global Pregabalin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. ZCL Chemicals Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 74. ZCL Chemicals Pregabalin Product Portfolios and Specifications
Table 75. ZCL Chemicals Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. ZCL Chemicals Main Business
Table 77. ZCL Chemicals Latest Developments
Table 78. Olon S.p.A. Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 79. Olon S.p.A. Pregabalin Product Portfolios and Specifications
Table 80. Olon S.p.A. Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Olon S.p.A. Main Business
Table 82. Olon S.p.A. Latest Developments
Table 83. AASraw Biochemical Technology Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 84. AASraw Biochemical Technology Pregabalin Product Portfolios and Specifications
Table 85. AASraw Biochemical Technology Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. AASraw Biochemical Technology Main Business
Table 87. AASraw Biochemical Technology Latest Developments
Table 88. Changzhou Pharmaceutical Factory (CPF) Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 89. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product Portfolios and Specifications
Table 90. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Changzhou Pharmaceutical Factory (CPF) Main Business
Table 92. Changzhou Pharmaceutical Factory (CPF) Latest Developments
Table 93. Almelo Pvt. Ltd. Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 94. Almelo Pvt. Ltd. Pregabalin Product Portfolios and Specifications
Table 95. Almelo Pvt. Ltd. Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Almelo Pvt. Ltd. Main Business
Table 97. Almelo Pvt. Ltd. Latest Developments
Table 98. Divi’s Laboratories Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 99. Divi’s Laboratories Pregabalin Product Portfolios and Specifications
Table 100. Divi’s Laboratories Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Divi’s Laboratories Main Business
Table 102. Divi’s Laboratories Latest Developments
Table 103. Angels Pharma Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 104. Angels Pharma Pregabalin Product Portfolios and Specifications
Table 105. Angels Pharma Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Angels Pharma Main Business
Table 107. Angels Pharma Latest Developments
Table 108. ARITE Pharmaceutical Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 109. ARITE Pharmaceutical Pregabalin Product Portfolios and Specifications
Table 110. ARITE Pharmaceutical Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. ARITE Pharmaceutical Main Business
Table 112. ARITE Pharmaceutical Latest Developments
Table 113. BAL Pharma Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 114. BAL Pharma Pregabalin Product Portfolios and Specifications
Table 115. BAL Pharma Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. BAL Pharma Main Business
Table 117. BAL Pharma Latest Developments
Table 118. Bazayan Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 119. Bazayan Pregabalin Product Portfolios and Specifications
Table 120. Bazayan Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Bazayan Main Business
Table 122. Bazayan Latest Developments
Table 123. Aurobindo Pharma Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 124. Aurobindo Pharma Pregabalin Product Portfolios and Specifications
Table 125. Aurobindo Pharma Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Aurobindo Pharma Main Business
Table 127. Aurobindo Pharma Latest Developments
Table 128. Hikal Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 129. Hikal Pregabalin Product Portfolios and Specifications
Table 130. Hikal Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Hikal Main Business
Table 132. Hikal Latest Developments
Table 133. Glenmark Life Sciences Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 134. Glenmark Life Sciences Pregabalin Product Portfolios and Specifications
Table 135. Glenmark Life Sciences Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Glenmark Life Sciences Main Business
Table 137. Glenmark Life Sciences Latest Developments
Table 138. Dongbang FTL Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 139. Dongbang FTL Pregabalin Product Portfolios and Specifications
Table 140. Dongbang FTL Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Dongbang FTL Main Business
Table 142. Dongbang FTL Latest Developments
Table 143. Teva Pharmaceutical Industries Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 144. Teva Pharmaceutical Industries Pregabalin Product Portfolios and Specifications
Table 145. Teva Pharmaceutical Industries Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. Teva Pharmaceutical Industries Main Business
Table 147. Teva Pharmaceutical Industries Latest Developments
Table 148. Divi’s Laboratories Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 149. Divi’s Laboratories Pregabalin Product Portfolios and Specifications
Table 150. Divi’s Laboratories Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 151. Divi’s Laboratories Main Business
Table 152. Divi’s Laboratories Latest Developments
Table 153. Chemo Iberica Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 154. Chemo Iberica Pregabalin Product Portfolios and Specifications
Table 155. Chemo Iberica Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 156. Chemo Iberica Main Business
Table 157. Chemo Iberica Latest Developments
Table 158. Maps Laboratories Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 159. Maps Laboratories Pregabalin Product Portfolios and Specifications
Table 160. Maps Laboratories Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 161. Maps Laboratories Main Business
Table 162. Maps Laboratories Latest Developments
Table 163. Laurus Labs Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 164. Laurus Labs Pregabalin Product Portfolios and Specifications
Table 165. Laurus Labs Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 166. Laurus Labs Main Business
Table 167. Laurus Labs Latest Developments
Table 168. Zhejiang Huahai Pharmaceutical Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 169. Zhejiang Huahai Pharmaceutical Pregabalin Product Portfolios and Specifications
Table 170. Zhejiang Huahai Pharmaceutical Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 171. Zhejiang Huahai Pharmaceutical Main Business
Table 172. Zhejiang Huahai Pharmaceutical Latest Developments
Table 173. Vasudha Pharma Chem Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 174. Vasudha Pharma Chem Pregabalin Product Portfolios and Specifications
Table 175. Vasudha Pharma Chem Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 176. Vasudha Pharma Chem Main Business
Table 177. Vasudha Pharma Chem Latest Developments
Table 178. Sun Pharmaceutical Industries Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 179. Sun Pharmaceutical Industries Pregabalin Product Portfolios and Specifications
Table 180. Sun Pharmaceutical Industries Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 181. Sun Pharmaceutical Industries Main Business
Table 182. Sun Pharmaceutical Industries Latest Developments
Table 183. CTX Life Sciences Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 184. CTX Life Sciences Pregabalin Product Portfolios and Specifications
Table 185. CTX Life Sciences Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 186. CTX Life Sciences Main Business
Table 187. CTX Life Sciences Latest Developments
Table 188. Srini Pharmaceuticals Basic Information, Pregabalin Manufacturing Base, Sales Area and Its Competitors
Table 189. Srini Pharmaceuticals Pregabalin Product Portfolios and Specifications
Table 190. Srini Pharmaceuticals Pregabalin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 191. Srini Pharmaceuticals Main Business
Table 192. Srini Pharmaceuticals Latest Developments


List of Figures
Figure 1. Picture of Pregabalin
Figure 2. Pregabalin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pregabalin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Pregabalin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pregabalin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pregabalin Sales Market Share by Country/Region (2024)
Figure 10. Pregabalin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tablet
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Oral Solution
Figure 14. Global Pregabalin Sales Market Share by Type in 2025
Figure 15. Global Pregabalin Revenue Market Share by Type (2020-2025)
Figure 16. Pregabalin Consumed in Hospitals
Figure 17. Global Pregabalin Market: Hospitals (2020-2025) & (K MT)
Figure 18. Pregabalin Consumed in Clinics
Figure 19. Global Pregabalin Market: Clinics (2020-2025) & (K MT)
Figure 20. Pregabalin Consumed in Others
Figure 21. Global Pregabalin Market: Others (2020-2025) & (K MT)
Figure 22. Global Pregabalin Sale Market Share by Application (2024)
Figure 23. Global Pregabalin Revenue Market Share by Application in 2025
Figure 24. Pregabalin Sales by Company in 2025 (K MT)
Figure 25. Global Pregabalin Sales Market Share by Company in 2025
Figure 26. Pregabalin Revenue by Company in 2025 ($ millions)
Figure 27. Global Pregabalin Revenue Market Share by Company in 2025
Figure 28. Global Pregabalin Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Pregabalin Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Pregabalin Sales 2020-2025 (K MT)
Figure 31. Americas Pregabalin Revenue 2020-2025 ($ millions)
Figure 32. APAC Pregabalin Sales 2020-2025 (K MT)
Figure 33. APAC Pregabalin Revenue 2020-2025 ($ millions)
Figure 34. Europe Pregabalin Sales 2020-2025 (K MT)
Figure 35. Europe Pregabalin Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Pregabalin Sales 2020-2025 (K MT)
Figure 37. Middle East & Africa Pregabalin Revenue 2020-2025 ($ millions)
Figure 38. Americas Pregabalin Sales Market Share by Country in 2025
Figure 39. Americas Pregabalin Revenue Market Share by Country (2020-2025)
Figure 40. Americas Pregabalin Sales Market Share by Type (2020-2025)
Figure 41. Americas Pregabalin Sales Market Share by Application (2020-2025)
Figure 42. United States Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Pregabalin Sales Market Share by Region in 2025
Figure 47. APAC Pregabalin Revenue Market Share by Region (2020-2025)
Figure 48. APAC Pregabalin Sales Market Share by Type (2020-2025)
Figure 49. APAC Pregabalin Sales Market Share by Application (2020-2025)
Figure 50. China Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 54. India Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Pregabalin Sales Market Share by Country in 2025
Figure 58. Europe Pregabalin Revenue Market Share by Country (2020-2025)
Figure 59. Europe Pregabalin Sales Market Share by Type (2020-2025)
Figure 60. Europe Pregabalin Sales Market Share by Application (2020-2025)
Figure 61. Germany Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 62. France Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Pregabalin Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Pregabalin Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Pregabalin Sales Market Share by Application (2020-2025)
Figure 69. Egypt Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Pregabalin Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pregabalin in 2025
Figure 75. Manufacturing Process Analysis of Pregabalin
Figure 76. Industry Chain Structure of Pregabalin
Figure 77. Channels of Distribution
Figure 78. Global Pregabalin Sales Market Forecast by Region (2026-2031)
Figure 79. Global Pregabalin Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Pregabalin Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Pregabalin Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Pregabalin Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Pregabalin Revenue Market Share Forecast by Application (2026-2031)